Liminatus Pharma Announces Board and Officer Changes
Ticker: LIMNW · Form: 8-K · Filed: Jul 11, 2025 · CIK: 1971387
| Field | Detail |
|---|---|
| Company | Liminatus Pharma, Inc. (LIMNW) |
| Form Type | 8-K |
| Filed Date | Jul 11, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, management-change
TL;DR
Liminatus Pharma (LMPX) reshuffled its board and officers on 7/10/25.
AI Summary
Liminatus Pharma, Inc. announced on July 10, 2025, changes in its board of directors and officer appointments. The company, formerly known as Iris Parent Holding Corp. until March 28, 2023, is incorporated in Delaware and operates in the biological products sector.
Why It Matters
Changes in a company's leadership and board can signal shifts in strategy or governance, impacting investor confidence and future performance.
Risk Assessment
Risk Level: low — This filing reports routine corporate governance changes and does not involve significant financial transactions or operational shifts.
Key Players & Entities
- Liminatus Pharma, Inc. (company) — Registrant
- Iris Parent Holding Corp. (company) — Former company name
- 20250710 (date) — Date of earliest event reported
- 20250711 (date) — Filing date
- Delaware (jurisdiction) — State of incorporation
FAQ
What specific changes were made to the board of directors and officer positions?
The filing indicates changes related to the 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers' but does not detail the specific individuals or roles affected in the provided text.
When was Liminatus Pharma, Inc. previously known as Iris Parent Holding Corp.?
The company's name was changed from Iris Parent Holding Corp. on March 28, 2023.
What is the primary business of Liminatus Pharma, Inc.?
Liminatus Pharma, Inc. is in the business of Biological Products (No Diagnostic Substances), with a Standard Industrial Classification code of 2836.
Where is Liminatus Pharma, Inc. headquartered?
The company's business and mailing address is 6 Centerpointe Drive, #625, La Palma, CA 90623.
What is the SEC file number for Liminatus Pharma, Inc.?
The SEC file number for Liminatus Pharma, Inc. is 001-42626.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 11, 2025 regarding Liminatus Pharma, Inc. (LIMNW).